Antibiotics impair immune checkpoint inhibitor effectiveness in hispanic patients with non-small cell lung cancer (AB-CLICaP)

Background The intestinal microbiota is an important factor in modulating immune‐mediated tumor cell destruction. Alterations in the microbiome composition have been linked to reduced efficacy of immune checkpoint inhibitor (ICI) therapies. Therefore, antibiotic treatment (ATB), which modifies the d...

Full description

Autores:

Ruiz-Patinõ, Alejandro
Barrón-Barrón, Feliciano
Cardona-Mendoza, Andrés Felipe
Corrales, Luis
Mas, Luis
Martín, Claudio Marcelo
Zatarain-Barrón, Zyanya Lucia
Recondo, Gonzalo
Ricaurte, Luisa María
Rojas Puentes, Leonardo
Archila, Pilar
Rodríguez, July F.
Sotelo-Rodríguez, Diana Carolina
Viola Muñoz, Lucía
Vargas Báez, Carlos Alberto
Carranza, Hernán
Otero, Jorge Miguel
Pino, Luis Eduardo
Rolfo, Christian
Rosell, Rafael Costa
Arrieta, Oscar

Tipo de recurso:

Article of journal

Fecha de publicación:

2020

Institución:

Universidad El Bosque

Repositorio:

Repositorio U. El Bosque

Idioma:

eng

OAI Identifier:

oai:repositorio.unbosque.edu.co:20.500.12495/3676

Acceso en línea:

http://hdl.handle.net/20.500.12495/3676
https://doi.org/10.1111/1759-7714.13573
https://repositorio.unbosque.edu.co

Palabra clave:

Antibiotics
Imunotherapy
Lung cancer

Rights

openAccess

License

Attribution-NonCommercial 4.0 International